Literature DB >> 29170036

Mucins, Mucus, and Goblet Cells.

Jonathan Ma1, Bruce K Rubin1, Judith A Voynow2.   

Abstract

The respiratory epithelium is lined by mucus, a gel consisting of water, ions, proteins, and macromolecules. The major macromolecular components of mucus are the mucin glycoproteins, which are critical for local defense of the airway. There are three classes of mucins in the airways: those that are secreted but do not polymerize (MUC7), those that are secreted and polymerize to form gels (MUC5AC, MUC5B), and those that have transmembrane domains and are cell surface associated (MUC1, MUC4, MUC16, MUC20). The mucins are regulated at the transcriptional, posttranscriptional, and epigenetic levels, and posttranslational modifications play an important role in mucin binding and clearance of microbes and pollutants. The development of mice deficient in specific mucins, and the cystic fibrosis pig, has greatly advanced our understanding of the role of mucins as innate immune mediators and how mucins and mucus contribute to lung disease. These observations suggest new strategies to ameliorate mucus obstruction by targeting mucociliary clearance and mucin hyperconcentration. Furthermore, a polymorphism in the promoter of MUC5B is strongly associated with risk of developing pulmonary fibrosis, supporting a novel function for MUC5B to influence interstitial lung disease. Exciting new data support the concept not only that mucins and mucus are important for lung homeostasis and protection from environmental threats but also that goblet cells play an important role as regulators of innate immune function. These insights into the innate immune properties of mucins and goblet cells support a shift from the current paradigm of repressing increased mucin expression to targeting regulation of specific mucins and the abnormal airway milieu.
Copyright © 2017 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COPD; asthma; cystic fibrosis; goblet cell; mucin

Mesh:

Substances:

Year:  2017        PMID: 29170036     DOI: 10.1016/j.chest.2017.11.008

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  76 in total

Review 1.  The role of mucosal barriers in human gut health.

Authors:  Kangseok Seo; Jeongmi Seo; Jiyoun Yeun; Haebin Choi; Young-In Kim; Sun-Young Chang
Journal:  Arch Pharm Res       Date:  2021-04-22       Impact factor: 4.946

2.  WNT/RYK signaling restricts goblet cell differentiation during lung development and repair.

Authors:  Hyun-Taek Kim; Wenguang Yin; Yuko Nakamichi; Paolo Panza; Beate Grohmann; Carmen Buettner; Stefan Guenther; Clemens Ruppert; Yasuhiro Kobayashi; Andreas Guenther; Didier Y R Stainier
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-27       Impact factor: 11.205

Review 3.  Innate Lymphoid Cell-Dependent Airway Epithelial and Inflammatory Responses to Inhaled Ozone: A New Paradigm in Pathogenesis.

Authors:  Jack R Harkema; James G Wagner
Journal:  Toxicol Pathol       Date:  2019-09-19       Impact factor: 1.902

Review 4.  Long Noncoding Transcriptome in Chronic Obstructive Pulmonary Disease.

Authors:  Dinesh Devadoss; Christopher Long; Raymond J Langley; Marko Manevski; Madhavan Nair; Michael A Campos; Glen Borchert; Irfan Rahman; Hitendra S Chand
Journal:  Am J Respir Cell Mol Biol       Date:  2019-12       Impact factor: 6.914

5.  The antioxidant N-acetylcysteine protects from lung emphysema but induces lung adenocarcinoma in mice.

Authors:  Marielle Breau; Amal Houssaini; Larissa Lipskaia; Shariq Abid; Emmanuelle Born; Elisabeth Marcos; Gabor Czibik; Aya Attwe; Delphine Beaulieu; Alberta Palazzo; Jean-Michel Flaman; Brigitte Bourachot; Guillaume Collin; Jeanne Tran Van Nhieu; David Bernard; Fatima Mechta-Grigoriou; Serge Adnot
Journal:  JCI Insight       Date:  2019-10-03

6.  Proteomic profile of saliva collected directly from ducts: a systematic review.

Authors:  Camilla Vieira Esteves; Wladimir Gushiken de Campos; Juliana Amorim Dos Santos; Solange Kobayashi Velasco; Eliete Neves Silva Guerra; Walter L Siqueira; Celso Augusto Lemos
Journal:  Clin Oral Investig       Date:  2019-12-12       Impact factor: 3.573

Review 7.  Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases.

Authors:  Itishri Sahu; A K M Ashiqul Haque; Brian Weidensee; Petra Weinmann; Michael S D Kormann
Journal:  Mol Ther       Date:  2019-03-06       Impact factor: 11.454

8.  HSP90 inhibitor geldanamycin reverts IL-13- and IL-17-induced airway goblet cell metaplasia.

Authors:  Alejandro A Pezzulo; Rosarie A Tudas; Carley G Stewart; Luis G Vargas Buonfiglio; Brian D Lindsay; Peter J Taft; Nicholas D Gansemer; Joseph Zabner
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

9.  Benzisothiazolinone upregulates the MUC5AC expression via ERK1/2, p38, and NF-κB pathways in airway epithelial cells.

Authors:  Soyoung Kwak; Yoon Seok Choi; Hyung Gyun Na; Chang Hoon Bae; Si-Youn Song; Hyung Geun Kim; Yong-Dae Kim
Journal:  Toxicol Res (Camb)       Date:  2019-07-16       Impact factor: 3.524

10.  The Innate Lymphoid System Is a Critical Player in the Manifestation of Mucoinflammatory Airway Disease in Mice.

Authors:  Brandon W Lewis; Ishita Choudhary; Kshitiz Paudel; Yun Mao; Rahul Sharma; Yong Wang; Jessy S Deshane; Richard C Boucher; Sonika Patial; Yogesh Saini
Journal:  J Immunol       Date:  2020-08-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.